Literature DB >> 2836335

Derivation and biochemical characterization of an enterovirus group-specific monoclonal antibody.

G E Yousef1, I N Brown, J F Mowbray.   

Abstract

This paper describes the derivation and characterization of monoclonal antibodies reactive with the group-specific epitopes of the VP1 peptide shared by enteroviruses. When tested against a wide range of the prototype strains of Coxsackie viruses A and B, polioviruses, and echoviruses, the monoclonal antibodies reacted with all of them in two or more assay systems. The virus of hepatitis A was the only enterovirus tested which was not recognized by these monoclonal antibodies. This finding is consistent with recent reports demonstrating genomic dissimilarity between this virus and the other enteroviruses. Although monoclonal antibodies have frequently been found to be assay specific, these particular antibodies were found to be equally effective in different immunochemical and biological assay systems. Biochemical characterization of one of these monoclonal antibodies is described and its potential usefulness for diagnosis is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2836335     DOI: 10.1159/000150012

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  24 in total

1.  Identification of enteroviruses by using monoclonal antibodies against a putative common epitope.

Authors:  Soo-Youn Shin; Ki-Soon Kim; Yoon-Sung Lee; Yoon-Seok Chung; Kwi-Sung Park; Doo-Sung Cheon; Byoung-Kuk Na; Yoonsung Kang; Hyang-Min Cheong; Youngjoon Moon; Jee-Hye Choi; Hang-Eui Cho; Na-Young Min; Jin-Sook Son; Young-Hoon Park; Youngmee Jee; Jae-Deuk Yoon; Chul-Yong Song; Kwang-Ho Lee
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

2.  Spectrum of monoclonal antibodies to coxsackievirus B-3 includes type- and group-specific antibodies.

Authors:  S Yagi; D Schnurr; J Lin
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

Review 3.  Nucleic acid detection systems for enteroviruses.

Authors:  H A Rotbart
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

4.  Effect of relative humidity and air temperature on survival of hepatitis A virus on environmental surfaces.

Authors:  J N Mbithi; V S Springthorpe; S A Sattar
Journal:  Appl Environ Microbiol       Date:  1991-05       Impact factor: 4.792

5.  Regional administration of oncolytic Echovirus 1 as a novel therapy for the peritoneal dissemination of gastric cancer.

Authors:  Erin S Haley; Gough G Au; Brian R Carlton; Richard D Barry; Darren R Shafren
Journal:  J Mol Med (Berl)       Date:  2009-01-13       Impact factor: 4.599

6.  Characterization of the recognition site and diagnostic potential of an enterovirus group-reactive monoclonal antibody.

Authors:  A Samuelson; M Forsgren; M Sällberg
Journal:  Clin Diagn Lab Immunol       Date:  1995-05

7.  Detection of enteroviruses from clinical specimens by spin amplification shell vial culture and monoclonal antibody assay.

Authors:  S L Klespies; D E Cebula; C L Kelley; D Galehouse; C C Maurer
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

8.  Detection of enteroviruses in the intestine of type 1 diabetic patients.

Authors:  M Oikarinen; S Tauriainen; T Honkanen; S Oikarinen; K Vuori; K Kaukinen; I Rantala; M Mäki; H Hyöty
Journal:  Clin Exp Immunol       Date:  2007-11-07       Impact factor: 4.330

9.  A new monoclonal antibody (Cox mAB 31A2) detects VP1 protein of coxsackievirus B3 with high sensitivity and specificity.

Authors:  Nicole Ettischer-Schmid; Andrea Normann; Martina Sauter; Lisa Kraft; Hubert Kalbacher; Reinhard Kandolf; Bertram Flehmig; Karin Klingel
Journal:  Virchows Arch       Date:  2016-08-27       Impact factor: 4.064

10.  Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3.

Authors:  H Zhang; G E Yousef; X Ouyang; L C Archard
Journal:  Int J Exp Pathol       Date:  1994-04       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.